JOIN THE BATTLE. Beat Rare Cancers.
In February and March 2020, thousands of people across the nation will Cycle for Survival. On 2014, Dena and her husband, Brad formed a team in San Francisco called Dena’s Dogs that was the top fundraising team in the United States in the Cycle for Survival movement. Weeks later, Dena lost her battle with Leiomiosarcoma, a rare cancer which effects one in five milion. Since then, Dena’s friends & family have continued to ride as Dena's Dogs in DC, SF, NYC and LA). Dena's Dogs, DC has been in the top 10 fund raisers in the DC area. This year, we want Dena’s Dogs DC to be the top fundraising team in DC if not the US! Will YOU donate? Will YOU ride? Help to honor Dena, her life and her legacy, and together we can fund research that may prevent others from losing loved ones to rare cancers.
In the photo: Dena, Brad and their sons at the San Francisco event in 2014.
100% of every dollar raised funds pioneering research.
We are committed to ensuring rare cancer patients get new and better treatment options. That's why we are raising money for Cycle for Survival. Our team's ride will fund research led by Memorial Sloan Kettering Cancer Center—benefiting patients worldwide.
Why this matters:
WE EACH HAVE A BATTLE CRY.
Rare cancers touch too many lives and hit too close to home. Together, we're united in this battle. Cycle for Survival is our way of making a difference.
RARE CANCERS ARE MORE COMMON THAN YOU THINK.
Approximately 50% of all cancer patients are fighting a rare cancer. These are familiar diseases: pediatric cancers, leukemia, lymphoma—and thyroid, ovarian and pancreatic cancers. All are among the many types classified as rare.
THERE AREN'T ENOUGH TREATMENT OPTIONS FOR PATIENTS.
Rare cancer patients often face limited or no treatment options. Cycle for Survival is committed to changing that by funding innovative clinical trials, studies, and research initiatives.
What you can do:
DONATE TO SUPPORT LIFESAVING RESEARCH!
Remember, every dollar helps patients and their families.
Thank you for your support—let us know if you're interested in riding, too!
If you think this page contains objectionable content, please inform the system administrator.